glp-1 agonist or antagonist Glucagon-like peptide-1 GLP-1 Medications for Weight Loss:

GLP-1RAs: Structure, Function, and Therapeutic Scope Molecular Basis: Endogenous GLP-1, Receptor Pharmacology, and Drug Engineering Endogenous GLP-1 is a 30amino-acid peptide generated by enzymatic processing of proglucagon in intestinal L-cells, pancreatic islet -cells, and neurons of the nucleus of the solitary tract [10, 18]

News Tips Got a confidential news tip

Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling

[DOI] [PubMed] [Google Scholar] 114.Mathiesen D.S., Bagger J.I., Bergmann N.C., Lund A., Christensen M.B., Vilsbll T., Knop F.K

Selection process Results from the databases search were imported in a reference management software and, after deduplication, were juxtaposed with the results from the additional search sources

The percentage of subjects achieving weight loss (liraglutide 78% versus exenatide 76%) and overall weight loss (liraglutide 3.24 kg versus exenatide 2.87 kg, p = 0.22) was similar between groups